Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Qiagen (QGEN) Restructuring Costs (2018 - 2025)

Historic Restructuring Costs for Qiagen (QGEN) over the last 8 years, with Q4 2025 value amounting to $22.4 million.

  • Qiagen's Restructuring Costs rose 169.94% to $22.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $54.5 million, marking a year-over-year decrease of 4670.7%. This contributed to the annual value of $54.5 million for FY2025, which is 4670.7% down from last year.
  • Per Qiagen's latest filing, its Restructuring Costs stood at $22.4 million for Q4 2025, which was up 169.94% from $8.1 million recorded in Q3 2025.
  • In the past 5 years, Qiagen's Restructuring Costs registered a high of $68.1 million during Q2 2024, and its lowest value of $3.0 million during Q4 2021.
  • Moreover, its 5-year median value for Restructuring Costs was $8.7 million (2023), whereas its average is $12.7 million.
  • Its Restructuring Costs has fluctuated over the past 5 years, first surged by 69144.39% in 2024, then plummeted by 7933.02% in 2025.
  • Quarter analysis of 5 years shows Qiagen's Restructuring Costs stood at $3.0 million in 2021, then soared by 172.86% to $8.1 million in 2022, then soared by 35.06% to $10.9 million in 2023, then skyrocketed by 102.91% to $22.1 million in 2024, then rose by 1.7% to $22.4 million in 2025.
  • Its Restructuring Costs was $22.4 million in Q4 2025, compared to $8.1 million in Q3 2025 and $14.1 million in Q2 2025.